Organon & Co. Stock News

Related Stocks: LMT , OGN , TSN , BTI , BUD , C ,

Sector ETF report for XPH

AdvisorNet Financial Inc purchased a new stake in Organon & Co. (NYSE:OGN) during the third quarter, HoldingsChannel.com reports. The firm purchased 1,609 shares of the companys stock, valued at approximately $53,000. Several other hedge funds also recently bought and sold shares of OGN. State of Alaska Department of Revenue acquired a new position in shares []

Deroy & Devereaux Private Investment Counsel Inc. increased its stake in shares of Organon & Co. (NYSE:OGN) by 32.3% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 613,274 shares of the companys stock after acquiring an additional 149,839 shares during the quarter. []

Organon & Co. (OGN) CEO Kevin Ali at 4th Annual Evercore ISI HealthCONx Conference (Transcript)

Manning & Napier Group LLC lessened its position in shares of Organon & Co. (NYSE:OGN) by 43.0% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 38,815 shares of the companys stock after selling 29,297 shares during the quarter. Manning & Napier Group []

Demars Financial Group LLC reduced its holdings in Organon & Co. (NYSE:OGN) by 28.2% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,061 shares of the companys stock after selling 2,772 shares during the quarter. Demars Financial Group LLCs holdings in Organon & []

Jacobs & Co. CA decreased its position in shares of Organon & Co. (NYSE:OGN) by 18.3% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,528 shares of the companys stock after selling 2,132 shares during the period. Jacobs & Co. CAs holdings in []

JERSEY CITY, N.J.--(BUSINESS WIRE)-- #Health--Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in

Carroll Financial Associates Inc. acquired a new position in Organon & Co. (NYSE:OGN) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 2,171 shares of the companys stock, valued at approximately $71,000. Several other large investors also recently bought and sold shares of []

Accenture has been selected by Organon to help establish and manage the transformation of the companys enterprise resource planning (ERP) technology into a cloud-based digital core that will improve patient and employee experiences. With a standardized technology platform that integrates business processes and people, Organon will have real-time analytics at its fingertips, allowing it to respond more rapidly to the needs of its patients, customers, and employees. Organon will use SAP S/4HANA to help simplify More The post Accenture to help build Organons enterprise capabilities with SAP S4/HANA on AWS appeared first on Help Net Security .

NEW YORK--(BUSINESS WIRE)--Accenture was selected by Organon to transform the companys enterprise resource planning technology into a cloud-based digital core.

Past spinoffs by other companies could bode well overall for J&J shareholders.

Related Stocks: VRSN , SKX , WPC , OGN , TTWO , LYB , CRSR , WELL , LNC , NFLX , AMT , INN ,